Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William B Mattes

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Toxicology and Applied Pharmacology|February 25, 2015
Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in childrenXi Yang, William F Salminen, Qiang Shi, et al.
Biomarkers in Medicine|September 15, 2023
US FDA public meeting: identification of concepts and terminology for multicomponent biomarkersAbena S Agyeman, Abbas Bandukwala, Khaled Bouri, et al.
International Journal of Toxicology|September 9, 2025
Validating and Using Cardiac NAMs for Toxicity Screening and Drug DevelopmentJennifer Beck Pierson, Anthony Bahinski, Brian Berridge, et al.
Science Translational Medicine|August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomicsHarald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Toxicology and Applied Pharmacology|February 25, 2015
Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in childrenXi Yang, William F Salminen, Qiang Shi, et al.
Biomarkers in Medicine|September 15, 2023
US FDA public meeting: identification of concepts and terminology for multicomponent biomarkersAbena S Agyeman, Abbas Bandukwala, Khaled Bouri, et al.
International Journal of Toxicology|September 9, 2025
Validating and Using Cardiac NAMs for Toxicity Screening and Drug DevelopmentJennifer Beck Pierson, Anthony Bahinski, Brian Berridge, et al.
Science Translational Medicine|August 27, 2010
Recommendations for biomarker identification and qualification in clinical proteomicsHarald Mischak, Günter Allmaier, Rolf Apweiler, et al.
Pageof 3